Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 5/20 | 0.41 |
| ▸ | SSTR5 | P35346 | 5/20 | 0.41 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.41 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.41 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 12/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30530241 | 0.92 | SSTR3 (0.41) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL29410615 | 0.84 | SSTR3 (0.41) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL26349625 | 0.81 | GPR119 (0.39) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL26349664 | 0.81 | TNF (0.39) | — | |
| SCHEMBL21058342 | 0.76 | SSTR3 (0.48) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL29410626 | 0.74 | PTPN1 (0.43) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL21058364 | 0.74 | SSTR3 (0.55) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL26349670 | 0.71 | NPC1 (0.40) | — | |
| SCHEMBL15143128 | 0.71 | L3MBTL1 (0.50) | SSTR3SSTR5SSTR2SSTR1SSTR4 | |
| SCHEMBL16076881 | 0.71 | SLC6A2 (0.48) | SSTR3SSTR5SSTR2SSTR1SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | REYOUNG CORPORATION (US) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303618-A1 | TRIPTOLIDE CONJUGATES AND USES THEREOF | TLR9, XIAP, ENPP2 | SSTR3 3941/4885SSTR5 2945/4885SSTR2 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.